Good morning, traders. Happy Tuesday, September 24th. The market is trying to climb and the Dow hit another trading high right after opening. Seven out of 11 sectors of the S&P 500 fell while energy, utilities, and manufacturing materials led the market.
My name is Kevin Travers; here are stonks and stories mooving the U.S. stock market today.
$Visa (V.US)$ was trading 4% lower Tuesday as regulatory concerns weighed on shares of the cre...

$Applied Therapeutics (APLT.US)$ $8

$Tesla (TSLA.US)$ i will sue him if it’s confirmed fake

$Cassava Sciences (SAVA.US)$The continuous statements that shorts made  and keep making  since 2021 on twitter should be considered defamatory  in court as these are  made every single day with the purpose of destroying the company reputation and profiting from short selling the stock, knowing that those statements on a daily basis will create doubt. It is also arrogant of them  to continue to keep making the same statements while in litigation.  Shouldn't there be a gag oder in place, judge?  Th...

$Cassava Sciences (SAVA.US)$Spoke to a former Vet that is now a Doctor  about simufilam and repairing  misfolded  protein as opposed to removing plaques in the brain like all the other failed drugs that got approved that caused brain bleeding and and killed people.  He stated how bad the plaque removal is for the body and the shock it causes to your neurons. It is a recipe for disaster and death to the body. But repairing misfolded protein in the brain is like restoring energy that decayed over t...

$Cassava Sciences (SAVA.US)$ Cassava Sciences Issues Statement on Former Science Advisor Jun 28, 2024:"Dr. Wang and his former public university medical school have had no involvement in the Company’s Phase 3 clinical trials of simufilam."